Simcere Pharmaceutical Group (HKSE:02096) Price-to-Free-Cash-Flow : N/A (As of Jun. 08, 2024)

Simcere Pharmaceutical Group Price-to-Free-Cash-Flow Chart

Simcere Pharmaceutical Group Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Free-Cash-Flow	Get a 7-Day Free Trial							-	-	40.35	-	-

Competitive Comparison of Simcere Pharmaceutical Group's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Simcere Pharmaceutical Group's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Simcere Pharmaceutical Group's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Simcere Pharmaceutical Group's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Simcere Pharmaceutical Group's Price-to-Free-Cash-Flow falls into.

Simcere Pharmaceutical Group Price-to-Free-Cash-Flow Calculation

Simcere Pharmaceutical Group's Price-to-Free-Cash-Flow ratio for today is calculated as

Simcere Pharmaceutical Group's Share Price of today is HK$5.97.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Simcere Pharmaceutical Group's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.35.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Simcere Pharmaceutical Group  (HKSE:02096) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.

Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.

Simcere Pharmaceutical Group Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Simcere Pharmaceutical Group's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Simcere Pharmaceutical Group (HKSE:02096) Business Description